CRO Quality Benchmarking Phase I Service Providers (2014)

QUALITY
CRO
BENCHMARKING
PHASE I
CRO Quality
Benchmarking
Phase I Service
Providers (2014)
Info@ISRreports.com

©2014 Industry Standard Research www.ISRreports.com
PREVIEW

www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 2
act with confidence
Report Overview
In its 6th year, ISR’s “CRO Quality Benchmarking Phase I Service Providers (2014)” report provides
pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality.
Respondents supplied satisfaction ratings from 435 service encounters across 28 Phase I CROs, making
this report the most comprehensive assessment of Phase I CRO service quality in the industry.
255Charts and Graphs
113Respondents
154Pages
435Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
• Phase I Leaders
• Proposal Volume
• Service Provider Usage
• Service Provider Preference
• Service Provider Cost Perceptions
2. Service Provider Selection Drivers
• Most Important Service Provider Attributes
• Service Provider Attributes Gaining Importance
3. Service Provider Performance and Scorecards Across Attributes
• “Staff Characteristics” Ratings
• “Operational Excellence” Ratings
• “Organizational and Finance” Ratings
• Performance Summary by Category
• Service Provider Loyalty
4. Service Provider Service Quality Profiles
5. All Study Data
How you can use this report:
Study Sponsors
• Make a more informed purchase of Phase
I services by understanding which service
providers best fit your company’s needs
• Broaden your Phase I CRO evaluation list by
accessing peer-based service quality ratings
across 28 critical attributes
• Pinpoint potential delivery concerns early
in a CRO relationship/ evaluation in order
to develop proactive strategies to address
potential gaps
Phase I Service Providers
• Uncover your own — and competitor —
delivery strengths and weaknesses
• Design messaging to tout your company’s
strengths
• Compete more effectively by understanding
buyers’ selection criteria and outsourcing
trends
NEXT: Companies Included
Report Structure:

act with confidence
Service Quality Metrics
• Metrics for minimizing
change orders
• Metrics for staff turnover
• Metrics for database lock
timelines
• Local market / Regulatory
knowledge
• Detailed plan for timely
project communications
• Project team chemistry
• Metrics for first patient / first
visit timelines
• Access to a broad range of
services
• Access to “unique” tests,
machines, equipment
• Location of Phase I unit(s)
within your country
• Financial strength / stability
• Metrics for site start-up
• Technology for real-time
access to data
• Timely access to open bed /
clinic space
• Offers innovative solutions
• Patient/ volunteer recruitment
strategy
• Responsiveness
• Metrics for data quality
• Up-front contingency
planning, risk management
• Low cost
• Location of Phase I unit(s) in
different global regions
• Metrics for meeting overall
project timelines
• Scientific knowledge
• Project manager quality
• Prior positive experience with
service provider
• Experience of the Phase I
unit’s lead investigator
• Access to patient populations
• Therapeutic expertise
CROs Included in this Report
• Biotrial
• CEDRA
• Celerion
• Charles River
• CHDR
• Chiltern
• Clinical Research Services
(CRS)
• Covance
• DaVita
• DCRI-Duke
• Frontage
• HungaroTrial
• ICON
• INC Research
• inVentiv Health Clinical
• Medpace
• PAREXEL
• PPD
• PRA
• Premier Research
• Quintiles
• Quotient Clinical
• Rho
• SGS Life Sciences
• Siro Clinpharm
• Theorem
• US Oncology
• WCCT Global
7% C-level
15% President/ VP
55% Director
21% Manager
2% Other
Participant Job Title Participant Geography Participant Company Size
60%
North
America
29%
Europe
Asia/
Other
11%
50% Large Companies
(R&D $1B or more)
27% Mid-Size
Companies (R&D
$100M-$999M)
23% Small Companies
(R&D less than $100M)
Report Metrics
Respondent Demographics (N=148)
Participant Experience: Mean = 17 years

act with confidence
Table of Contents
For full table of contents and additional sample pages, download the full
preview from our website: http://bit.ly/Phase1CRO

act with confidence
act with confidence
Introduction
www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 7
Introduction
Welcome to ISR’s 2014 CRO Quality Benchmarking Phase I Service Providers report�
This report marks the sixth edition of this study and, though the study design is
revisited and refreshed each year to account for evolution within the industry, the
impetus for performing this research remains the same� Over time, Industry Standard
Research has accumulated a wealth of knowledge around service quality and CRO
performance� Understanding and utilizing this information allows stakeholders within
the industry to make informed decisions when choosing a CRO for Phase I services�
ISR knows that selecting a CRO isn’t easy� There are a myriad of factors to evaluate
for each CRO being considered� Does the provider have the necessary therapeutic
expertise? Will the trial be completed on time and within budget? Will the provider
have sufficient access to patients? Does the lead investigator have sufficient
experience? Without prior experience with a provider, purchasers of CRO services
are often forced to rely on incomplete or biased assessments of CRO performance
passed on through word of mouth from peers within the industry�
In the CRO Quality Benchmarking Phase I report, ISR provides the data necessary to
answer these questions – and many more – with confidence� 113 decision-makers
have weighed in with their CRO selection criteria and outsourcing behaviors� They
have provided feedback on 435 recent service encounters across 28 Phase I CROs�
17 providers have received detailed profiles, eight large, multi-service CROs; six
non-large, multi-service CROs; and three Phase I focused CROs� Find out in which
areas large CROs dominate and in which performance areas the smaller or more
focused CROs shine�
Not only does this report enable more educated purchases of CRO services, it also
allows Phase I service providers to get a behind-the-scenes look at customers’
perceptions of their performance� Providers can determine areas of strength and
understand where they may need to close the gap relative to competitors� As
they say, knowledge is power� Having a grasp on customer beliefs, attitudes, and
experiences will help CROs effectively promote their strengths and improve areas in
which they are falling short�
Sample Page

act with confidence
act with confidence
Service Provider Performance and Scorecards Across Attributes
Figure 2 – “Operational
Excellence” Ratings
Performance in Operational Excellence shows more variability among Phase I
providers� The non-large, multi-service providers Quotient Clinical and SGS Life
Sciences stand out for going beyond expectations as well as Phase I focused provider
Clinical Research Services (CRS)� Respondents also rate PPD as more frequently
exceeding expectations in Operational Excellence compared to other large, multi-
service providers�
Technology
for real-time
access to
data
Speed of
site
start-up
Data
Quality
Local
market /
regulatory
knowledge
Meeting
Overall
Project
Timelines
Meeting
Database
Lock
Timelines
Meeting
First Patient
/ First Visit
Timelines
Offers
Innovative
Solutions
Patient /
Volunteer
Recruitment
Up-front
contingency
planning, risk
management
Timely project
communications
Covance
ICON
INC Research
inVentiv Health Clinical
PAREXEL
PPD
PRA
Quintiles
Charles River
Medpace
Premier Research
Quotient Clinical
SGS Life Sciences
US Oncology
Celerion
Clinical Research Services (CRS)
WCCT Global
Operational Excellence
LARGE MULTI-SERVICE CROS
NON-LARGE MULTI-SERVICE CROS
PRIMARILY PHASE I FOCUSED CROS
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deﬁciency
© Industry Standard Research
Sample Page
Technology
for real-time
access to
data
Speed of
site
start-up
Data
Quality
Local
market /
regulatory
knowledge
Meeting
Overall
Project
Timelines
Meeting
Database
Lock
Timelines
Meeting
First Patient
/ First Visit
Timelines
Offers
Innovative
Solutions
Patient /
Volunteer
Recruitment
Up-front
contingency
planning, risk
management
Timely project
communications
Company A
Company B
Company C
Company D
Company E
Company F
Company G
Company H
Company I
Company J
Company L
Company M
Company N
Company O
Company P
Company Q
Company R
Operational Excellence
LARGE MULTI-SERVICE CROS
NON-LARGE MULTI-SERVICE CROS
PRIMARILY PHASE I FOCUSED CROS
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deﬁciency
Figure 2 – “Operational Excellence” Ratings

act with confidence
act with confidence
Study Data
Sponsor Preferences
Scenario Trade-offs
“Would you prefer…?” (Base = 113)
CRO QUALITY BENCHMARKING PHASE I 143
25%
75%
20% lower cost of a study
Reaching patient recruitment goals 10% faster within the
study
76%
24%
A CRO oﬀer you recruitment guarantees d
them controlling site selection
To maintain control over site selection wi
recruitment guarantees
Sponsor Preferences
Scenario Trade-offs
CRO QUALITY BENCHMARKING PHASE I 143
25%
75%
20% lower cost of a study
Reaching patient recruitment goals 10% faster within the
study
76%
24%
A CRO oﬀer you recruitment guarantees driven by
them controlling site selection
To maintain control over site selection with no
recruitment guarantees
Sponsor Preferences
Scenario Trade-offs
Sample Page

act with confidence
Sample PageSample Page
For full table of contents and additional sample pages, download the full
preview from our website: http://bit.ly/Phase1CRO

act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services
industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.

For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at
www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.
About Industry Standard Research
Save on this,
or any ISR
report, by
registering a
free account
Register now
• Receive a $250 instant credit towards any ISR report
• Earn 10% credit towards all future purchases
• Receive advanced notifications on ISR’s latest reports and free resources
For pricing and ordering information, please visit our website:
http://bit.ly/Phase1CRO

act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10
act with confidence
The ISR Difference
Custom-quality syndicated market research
www.ISRreports.com
ISR's Reports
The Common
Syndicated Reportvs.
How confident are you?
vs.
DataCollection
ISR's proprietary data collection
tools and channels support fast,
high quality data collection
Struggle to recruit the right
targets and enough of them
vs.
SampleSizes
Robust sample sizes that
instill confidence
Often insufficient industry
representation that leaves you
defending results
vs.vs.
Research methods
Mostly primary
research;
always appropriate
for the topic
One size fits all;
usually publically
available data
vs.vs.
Respondents
Sophisticated screening
ensures genuine
decision-makers
Undisclosed
methodologies and
respondent demographics
vs.vs.
Analysts
Decades of experience
means more insights that are
immediately usable
Junior analysts capable of
reporting numbers

CRO Quality Benchmarking Phase I Service Providers (2014)

Recomendados

Recomendados

Más contenido relacionado

Más de Industry Standard Research

Más de Industry Standard Research (20)

Último

Último (20)

CRO Quality Benchmarking Phase I Service Providers (2014)